12.1 Antepartum Health, Prenatal Assessment, and Screening

12.1 Antepartum Health, Prenatal Assessment, and Screening

Antepartum nursing care encompasses the comprehensive health promotion, clinical risk assessment, physiological surveillance, and psychosocial support provided to a pregnant woman from conception until the onset of labor. Systematic prenatal care is essential for reducing maternal and neonatal morbidity and mortality, identifying pre-existing or emergent gestational complications, and establishing baseline maternal-fetal physiological parameters.

---

Diagnostic Classification of Pregnancy Signs

Clinical manifestations of pregnancy are categorized into three distinct diagnostic tiers based on their specificity: presumptive, probable, and positive signs. Accurate differentiation is critical for clinical assessment and licensing examinations.

1. Presumptive Signs (Subjective Maternal Findings)

Presumptive signs are subjective physiological symptoms experienced and reported exclusively by the pregnant woman. While strongly suggestive of pregnancy, they lack diagnostic certainty because they can be caused by underlying endocrine imbalances, gastrointestinal disorders, acute infections, or stress.

• Amenorrhea: Cessation of menses caused by continuous progesterone secretion from the corpus luteum (and subsequently the placenta), preventing endometrial sloughing. Alternative etiologies include hypothalamic dysfunction, severe psychological stress, strenuous athletic training, rapid weight loss, or endocrine disorders (e.g., polycystic ovary syndrome, hyperprolactinemia).
• Nausea and Vomiting ("Morning Sickness"): Typically manifesting between 4 and 6 weeks of gestation and peaking around 8 to 12 weeks; driven by surging human chorionic gonadotropin (hCG) and estrogen levels. Alternative etiologies include gastroenteritis, cholecystitis, peptic ulcer disease, or food poisoning.
• Breast Changes and Tenderness: Tingling, fullness, hypersensitivity, and darkening of the areola occurring within the first few weeks due to estrogen- and progesterone-mediated ductal and alveolar hypertrophy. Alternative etiologies include premenstrual hormonal fluctuations, fibrocystic breast changes, or oral contraceptive use.
• Urinary Frequency: Increased urinary frequency in the first trimester caused by the expanding pelvic uterus compressing the maternal urinary bladder. This symptom transiently remits in the second trimester as the uterus ascends into the abdominal cavity, returning in the third trimester as the presenting part descends. Alternative etiologies include urinary tract infection, diabetes mellitus, or increased caffeine intake.
• Excessive Fatigue: Profound lethargy and exhaustion driven by high circulating progesterone concentrations and increased metabolic demands. Alternative etiologies include anemia, depression, hypothyroidism, or acute systemic infection.
• Quickening: The first maternal perception of fetal movement, typically described as a faint "flutter." Experienced around 18 to 20 weeks of gestation in primigravidas and as early as 14 to 16 weeks in multiparous women. Alternative etiologies include excessive intestinal peristalsis, flatus, or abdominal muscle contractions.

2. Probable Signs (Objective Physical & Laboratory Findings)

Probable signs are objective physical modifications of the pelvic organs and systemic biological markers identified by a trained healthcare examiner. Although these findings provide strong physical evidence of pregnancy, they do not provide definitive diagnostic proof because non-gestational pelvic pathology or trophoblastic tumors can produce identical changes.

• Goodell Sign: Marked softening of the cervix and vaginal portion of the uterine neck occurring around 6 weeks of gestation. Triggered by heightened pelvic vasocongestion and cervical vascular hypertrophy. Alternative etiologies include hormonal therapy or pelvic inflammatory states.
• Chadwick Sign: A distinctive bluish-violet discoloration of the vaginal mucosa, vulva, and cervix, observable upon speculum examination as early as 6 to 8 weeks of gestation. Resulting from profound venous congestion and hyperemia of the pelvic vasculature. Alternative etiologies include pelvic congestion syndrome or pelvic pelvic masses.
• Hegar Sign: Softening and compressibility of the lower uterine segment (the uterine isthmus) detectable on bimanual pelvic examination around 6 to 8 weeks of gestation. The uterine isthmus softens to such a degree that the fundus and cervix feel like separate entities.
• Braxton Hicks Contractions: Intermittent, irregular, painless uterine contractions that occur throughout pregnancy and become palpable around the fourth month (16 weeks). They do not increase in intensity, duration, or frequency, and they do not produce progressive cervical dilation or effacement.
• Ballottement: A clinical palpation technique performed between 16 and 28 weeks of gestation. The examiner inserts two gloved fingers into the vagina and sharply taps the anterior lower uterine segment; the floating fetus ascends into the amniotic fluid and then falls back, gently rebounding against the examiner's fingertips. Alternative etiologies include uterine fibroids or pelvic ascites.
• Abdominal Uterine Enlargement: Progressive, measurable expansion of the uterus above the pubic symphysis. By 12 weeks, the fundus is palpable at the pubic symphysis; by 20 weeks, it reaches the umbilicus. Alternative etiologies include uterine leiomyomas, ovarian cysts, or ascites.
• Positive Pregnancy Tests (hCG Detection): Detection of human chorionic gonadotropin in maternal urine or serum. Trophoblastic tissue secretes hCG following blastocyst implantation (detected in maternal serum as early as 8 to 10 days post-conception). However, elevated hCG can occur with gestational trophoblastic disease (hydatidiform mole / choriocarcinoma), germ cell neoplasms, or cross-reactivity with pituitary luteinizing hormone.

3. Positive Signs (Definitive Diagnostic Proof)

Positive signs are clinical findings that can be attributed solely and directly to the presence of a living fetus. They cannot be simulated by any maternal pathology or benign condition and provide indisputable confirmation of pregnancy.

• Visualization of the Fetus by Ultrasound: Transvaginal sonography reliably demonstrates a gestational sac by 4.5 to 5 weeks of gestation, an embryo with active cardiac motion by 5.5 to 6 weeks, and transabdominal ultrasound visualizes structural fetal anatomy by 7 to 8 weeks.
• Auscultation of Fetal Heart Tones (FHT): Detection of an independent fetal heartbeat distinct from the maternal pulse. Fetal heart sounds are auscultated via an ultrasonic Doppler device at 10 to 12 weeks of gestation (normal range: 110 to 160 beats per minute). A non-electronic fetoscope or Pinard stethoscope detects fetal heart tones later, between 18 and 20 weeks of gestation.
• Fetal Movement Palpated or Observed by an Examiner: Active fetal movements felt, palpated, or visibly confirmed by an experienced healthcare professional (usually after 20 weeks of gestation). Maternal perception alone does not qualify as a positive sign.

---

Comparison Matrix: Diagnostic Signs of Pregnancy

---

Obstetric History & Gestational Calculations

Accurate gestational dating and precise recording of gravidity and parity form the foundation of clinical antepartum management.

1. Naegele's Rule for Estimating Date of Delivery (EDD)

Naegele's rule is the standard clinical formula used to calculate the Estimated Date of Delivery (EDD) based on the first day of the normal Last Menstrual Period (LMP), assuming a regular 28-day menstrual cycle.

$\text{EDD} = \text{First Day of LMP} - 3 \text{ Months} + 7 \text{ Days} + 1 \text{ Year}$

Step-by-Step Clinical Calculation Protocol:

1. Identify the exact first calendar day of the patient's normal LMP.
2. Subtract 3 calendar months from that month.
3. Add 7 calendar days to the day of the LMP.
4. Add 1 year to the calendar year (adjusting for month roll-over).

Clinical Example 1:

• Patient reports the first day of her LMP was October 14, 2025.
• Subtract 3 months: October (month 10) - 3 = July (month 7).
• Add 7 days: 14 + 7 = 21.
• Add 1 year: 2025 + 1 = 2026.
• Calculated EDD: July 21, 2026.

Clinical Example 2 (Month-End Boundary Adjustment):

• Patient reports the first day of her LMP was January 28, 2026.
• Subtract 3 months: January (month 1) - 3 = October of previous year (month 10).
• Add 7 days: 28 + 7 = 35 days. Since October has 31 days, roll into November: 35 - 31 = November 4.
• Adjust year: The pregnancy concludes in the same calendar year: November 4, 2026.

2. Obstetric Parity Coding: The GTPAL Classification System

Obstetric history is recorded using either the abbreviated two-digit Gravida / Para (GP) system or the comprehensive five-digit GTPAL acronym. The GTPAL framework eliminates ambiguity regarding pregnancy outcomes, gestational duration, and multiple gestations.

 G ──► GRAVIDA: Total number of all pregnancies (including current, regardless of outcome)
 T ──► TERM: Deliveries occurring at ≥ 37 weeks 0 days gestation (viable or stillborn)
 P ──► PRETERM: Deliveries occurring between 20 weeks 0 days and 36 weeks 6 days
 A ──► ABORTIONS: Pregnancies ending before 20 weeks 0 days (spontaneous or elective)
 L ──► LIVING: Total number of currently living biological children

Critical GTPAL Rules for the Registered General Nurse:

• Gravida (G): Reflects total pregnancies, including the current pregnancy, miscarriages, terminations, ectopic gestations, and molar pregnancies. A multiple gestation (twins, triplets) counts as one single pregnancy event (G = 1).
• Term (T) & Preterm (P): These parameters count delivery events (episodes of birth), not the number of individual neonates born. A delivery of twin infants at 38 weeks gestation counts as one term delivery (T = 1).
• Abortions (A): Any pregnancy termination occurring prior to 20 weeks 0 days of gestation, whether spontaneous miscarriage, therapeutic abortion, or ectopic pregnancy. Loss at >= 20 weeks is categorized as a stillbirth (preterm or term delivery).
• Living (L): Counts individual living children alive at the time of history taking. Here, twins count individually as two living children (L = 2).

Worked Clinical Case Scenario:

A 32-year-old female presents to the prenatal clinic for her initial visit. Her obstetric history reveals: she is currently pregnant; she delivered full-term twins at 38 weeks who are healthy and living; she delivered a singleton infant at 34 weeks who is healthy and living; she experienced one spontaneous miscarriage at 10 weeks gestation; and she had an elective termination at 8 weeks gestation.

• Gravida (G): Current pregnancy (1) + Twins (1) + Preterm infant (1) + Miscarriage (1) + Elective termination (1) = 5
• Term (T): Delivery event of twins at 38 weeks = 1
• Preterm (P): Delivery event of singleton at 34 weeks = 1
• Abortions (A): Miscarriage at 10 weeks (1) + Abortion at 8 weeks (1) = 2
• Living (L): Twin 1 + Twin 2 + Preterm singleton = 3
• Final GTPAL Score: G5-T1-P1-A2-L3 (or Gravida 5, Para 2).

---

Maternal Physiological Adaptations to Pregnancy

Pregnancy elicits profound anatomical and physiological adaptations across every maternal organ system to support fetal development and prepare for labor.

1. Cardiovascular System Adaptations

• Intravascular Volume Expansion: Total maternal blood volume increases dramatically by 40% to 50% (approximately 1,200 to 1,500 mL) above non-pregnant baselines. Plasma volume increases by 45% to 50%, whereas red blood cell (RBC) mass increases by only 20% to 30% (stimulated by renal erythropoietin).
• Physiologic Anemia of Pregnancy (Hemodilution): Because plasma volume expansion significantly outpaces erythrocyte production, the hematocrit and hemoglobin concentration experience a dilutional decrease.
  • True pathologic antepartum anemia is defined by clinical guidelines as Hemoglobin < 11.0 g/dL (hematocrit < 33%) in the first and third trimesters, or Hemoglobin < 10.5 g/dL (hematocrit < 32%) in the second trimester.
  • Routine oral elemental iron supplementation (30 to 60 mg/day) is prescribed to prevent true iron deficiency anemia.
• Cardiac Output & Heart Rate: Cardiac output increases by 30% to 50%, driven by an increase in stroke volume and an increase in resting heart rate of 10 to 15 beats per minute.
• Systemic Vascular Resistance & Blood Pressure: Progesterone induces systemic vascular smooth muscle relaxation and nitric oxide release, decreasing systemic vascular resistance (SVR). Blood pressure drops slightly during the second trimester (diastolic drops 5 to 10 mmHg), returning to pre-pregnancy baseline levels by term. A blood pressure >= 140/90 mmHg is never normal.
• Supine Hypotensive Syndrome (Aortocaval Compression): When a pregnant woman lies flat on her back (supine) after mid-pregnancy (>= 20 weeks), the heavy gravid uterus compresses the inferior vena cava (IVC) against the vertebral column.
  • Hemodynamics: Marked reduction in venous return to the right atrium -> sharp decline in stroke volume and cardiac output (drops up to 25% to 30%) -> systemic hypotension, cerebral hypoperfusion, and compromised uteroplacental blood flow.
  • Signs & Symptoms: Maternal lightheadedness, dizziness, diaphoresis, pallor, nausea, syncope, and fetal bradycardia.
  • Mandatory Nursing Intervention: Immediately position the patient in the left lateral recumbent position, or place a wedge under her right hip to displace the gravid uterus laterally off the vena cava.

2. Respiratory, Renal, & Metabolic Adaptations

• Respiratory: The expanding uterus elevates the diaphragm by approximately 4 cm. Maternal tidal volume increases by 30% to 40%, and minute ventilation rises, creating a state of physiological, compensated chronic mild respiratory alkalosis (arterial pH 7.40 to 7.45, PaCO2 27 to 32 mmHg, serum HCO3- 18 to 22 mEq/L). This gradient facilitates passive carbon dioxide transfer from fetal to maternal circulation.
• Renal & Urinary: Renal blood flow and glomerular filtration rate (GFR) increase by 50%. Consequently, normal serum creatinine and blood urea nitrogen (BUN) levels decline significantly (normal pregnancy creatinine is 0.4 to 0.8 mg/dL; a serum creatinine > 1.0 mg/dL indicates underlying renal impairment). Progesterone induces ureteral dilation and physiological hydronephrosis (predominantly right-sided), causing urinary stasis and predisposing the mother to asymptomatic bacteriuria and pyelonephritis.
• Endocrine: Human placental lactogen (hPL), human chorionic somatomammotropin, cortisol, and prolactin act as insulin antagonists in the second half of pregnancy, inducing peripheral insulin resistance to spare maternal glucose for transfer across the placenta to the developing fetus.

---

Maternal Physiological Adaptations Summary Table

---

Universal Antepartum Laboratory Screening Protocols

Routine prenatal care follows standardized schedules of clinical laboratory assessments to identify maternal and fetal risk factors early.

1. Initial Trimester Laboratory Battery

• Blood Type, Rh Factor, & Antibody Screen (Indirect Coombs Test): Identifies Rh-negative status and detects atypical erythrocyte antibodies.
• Complete Blood Count (CBC): Evaluates baseline hemoglobin, hematocrit, and platelet count.
• Infectious Disease Panel: Rubella antibody titer (rubella non-immune mothers require subcutaneous MMR immunization postpartum; MMR is a live-attenuated vaccine and strictly contraindicated during pregnancy), Hepatitis B Surface Antigen (HBsAg), HIV antibody screening, Syphilis serology (VDRL or RPR), and baseline urine culture to detect asymptomatic bacteriuria (treated promptly to prevent preterm labor).

2. Rh Alloimmunization & The RhoGAM Protocol

Rh incompatibility occurs when an Rh-negative mother (dd) carries an Rh-positive fetus (Dd) inheriting the Rh antigen from the father. If fetal erythrocytes enter the maternal intravascular circulation during birth, trauma, or invasive procedures, the maternal immune system recognizes the Rh(D) antigen as foreign and mounts an immune response, producing anti-D immunoglobulin M (IgM) followed by immunoglobulin G (IgG) antibodies (alloimmunization / sensitization).

• Pathophysiology in Subsequent Pregnancies: While the first Rh-positive child is usually unaffected, maternal anti-D IgG antibodies produced during sensitization cross the placenta in subsequent Rh-positive pregnancies, binding to fetal erythrocytes and causing hemolysis, severe fetal anemia, erythroblastosis fetalis, profound hydrops fetalis, and intrauterine demise.
• The Indirect Coombs Test: Performed on maternal blood to evaluate whether the Rh-negative woman has developed circulating anti-D antibodies. If the indirect Coombs is negative, the mother is unsensitized and is eligible to receive Rh immune globulin.
• RhoGAM (Rh[D] Immune Globulin) Administration Protocol:
  • Routine Antepartum Prophylaxis: 300 mcg IM administered universally at 28 weeks of gestation to all unsensitized Rh-negative women.
  • Postpartum Administration: 300 mcg IM administered within 72 hours after delivery if the neonate's cord blood confirms Rh-positive status and the direct Coombs test on neonatal blood is negative.
  • Sensitizing Events (Antepartum Indications): Administer 300 mcg IM (or 50 mcg micro-dose if < 13 weeks) within 72 hours of any event involving potential fetomaternal hemorrhage: spontaneous miscarriage, elective abortion, ectopic pregnancy, abdominal trauma, chorionic villus sampling (CVS), amniocentesis, or external cephalic version.
  • Critical Clinical Distinction: Once an Rh-negative mother is sensitized (indirect Coombs test is positive), RhoGAM is completely ineffective. Management shifts to serial maternal antibody titers, middle cerebral artery (MCA) Doppler velocimetry to detect fetal anemia, and possible intrauterine fetal transfusions.

3. Gestational Diabetes Mellitus (GDM) Screening

Gestational diabetes mellitus is defined as carbohydrate intolerance with onset or first recognition during pregnancy. Elevated human placental lactogen (hPL), cortisol, and progesterone cause physiological peak peripheral insulin resistance during the late second and early third trimesters.

• Timing: Universal screening is conducted between 24 and 28 weeks of gestation (or during the first trimester in high-risk women with severe obesity, prior GDM, or polycystic ovary syndrome).
• Screening Modality (The Two-Step Approach):
  1. Step 1: 1-Hour 50-g Oral Glucose Challenge Test (GCT):
     • Administered without regard to fasting or time of day. The patient ingests a 50-g oral glucose load, and venous plasma glucose is drawn exactly 1 hour later.
     • Threshold: A plasma glucose value >= 130 to 140 mg/dL (7.2 to 7.8 mmol/L) is considered positive (abnormal) and mandates proceeding to the diagnostic 3-hour test.
  2. Step 2: Diagnostic 3-Hour 100-g Oral Glucose Tolerance Test (OGTT):
     • Patient must maintain an unrestricted carbohydrate diet for 3 days prior, fast overnight for 8 to 14 hours, and avoid smoking.
     • Baseline fasting glucose is drawn, followed by ingestion of a 100-g oral glucose solution. Plasma glucose levels are drawn at 1, 2, and 3 hours.
     • Carpenter-Coustan Diagnostic Thresholds:
       • Fasting: >= 95 mg/dL (5.3 mmol/L)
       • 1-Hour: >= 180 mg/dL (10.0 mmol/L)
       • 2-Hour: >= 155 mg/dL (8.6 mmol/L)
       • 3-Hour: >= 140 mg/dL (7.8 mmol/L)
     • Diagnostic Criteria: Diagnosis of GDM is confirmed when two or more of the four glucose values meet or exceed these thresholds.
• Clinical Targets & Therapy: First-line management is medical nutritional therapy and moderate physical exercise. Target blood glucose levels: Fasting <= 95 mg/dL and 2-hour postprandial <= 120 mg/dL (or 1-hour <= 140 mg/dL). If lifestyle modifications fail, subcutaneous human insulin is the pharmacological treatment of choice because it does not cross the placental barrier.

4. Group B Streptococcus (GBS) Screening & Intrapartum Prophylaxis

Group B Streptococcus (Streptococcus agalactiae) is a common gram-positive bacterium that colonizes the maternal gastrointestinal and lower genital tracts in 20% to 30% of healthy women. While asymptomatic in the mother, vertical transmission during labor and passage through the birth canal can cause devastating early-onset neonatal sepsis, pneumonia, and meningitis.

• Screening Protocol: Universal screening is performed at 35 to 37 weeks of gestation using a single swab inserted into the lower vaginal introitus and then through the anal sphincter (rectal swab) without speculum examination.
• Indications for Intrapartum Antibiotic Prophylaxis (IAP):
  • Positive GBS vaginal-rectal screening culture during the current pregnancy.
  • GBS bacteriuria documented at any point during the current pregnancy.
  • History of a previous infant with invasive early-onset GBS disease.
  • Unknown GBS culture status at the onset of labor with any of the following intrapartum risk factors: preterm labor (< 37 weeks 0 days), prolonged rupture of membranes (>= 18 hours), or maternal intrapartum core temperature >= 38.0°C (100.4°F).
  • Exception: Planned Cesarean delivery performed prior to the onset of labor and with intact amniotic membranes does not require GBS prophylaxis, regardless of colonization status.
• Pharmacological Regimen & Timing:
  • First-Line Drug: Intravenous Penicillin G — initial loading dose of 5 million units IV, followed by 2.5 to 3.0 million units IV every 4 hours until delivery. (Alternative: Ampicillin 2 g IV initial load, then 1 g IV every 4 hours).
  • Critical Clinical Timing Benchmark: Antibiotic prophylaxis must be initiated at least 4 hours prior to delivery to achieve therapeutic bactericidal levels in maternal amniotic fluid and fetal serum.
  • Penicillin Allergy Regimens: Cefazolin 2 g IV load then 1 g q8h (if low risk for anaphylaxis); Clindamycin 900 mg IV q8h (only if culture confirms clindamycin susceptibility); or IV Vancomycin (20 mg/kg q8h, maximum 2 g) if high risk for anaphylaxis or clindamycin-resistant.